Zhen Li is the founder of ADARx Pharmaceuticals. ADARx Pharmaceuticals has raised $200M in total funding. Latest round: Series C.
Zhen Li is the CEO of ADARx Pharmaceuticals, a clinical-stage biotechnology company located in San Diego, specializing in developing next-generation RNA therapeutics. Her background includes a Ph.D. in chemistry and chemical biology from Harvard, and prior experience at Merck, which inspired her to pursue a career in biopharma. ADARx Pharmaceuticals recently closed an oversubscribed $200 million Series C financing round to advance its clinical programs for diseases like hereditary angioedema and other complement-mediated conditions.
Full founder directory · Investor directory · Company funding database · Fundraising library